On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Altoona Center for Clinical Research

InstitutionResearch output, impact & collaborations

Altoona Center for Clinical Research is a institution indexed in ScholarIQ from OpenAlex.

What is known about Altoona Center for Clinical Research?

ScholarIQrecord summary

Altoona Center for Clinical Research is a research organisation in Duncansville, United States. OpenAlex records 405 works and 19,224 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Altoona Center for Clinical Research have?

ScholarIQindexed works

Altoona Center for Clinical Research has 405 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Altoona Center for Clinical Research have?

ScholarIQcitation count

Altoona Center for Clinical Research has 19,224 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Altoona Center for Clinical Research?

ScholarIQresearcher count

Altoona Center for Clinical Research has 1 researchers in the ScholarIQ index.

What is the average h-index at Altoona Center for Clinical Research?

ScholarIQavg h-index

Altoona Center for Clinical Research has an average h-index of 76 in OpenAlex.

What is the ROR of Altoona Center for Clinical Research?

ScholarIQror

The ROR for Altoona Center for Clinical Research is on the source record.

What is the OpenAlex record for Altoona Center for Clinical Research?

ScholarIQopenalex

The OpenAlex for Altoona Center for Clinical Research is on the source record.

Who are the most-cited researchers behind Altoona Center for Clinical Research?

ScholarIQtop researchers by citations
1
Alan Kivitz · Rheumatoid Arthritis Research and Therapies
348 works20,177 citations

What are the most-cited papers on Altoona Center for Clinical Research?

ScholarIQmost cited works
Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
Lee S. Simon, Arthur L. Weaver, David Y. Graham, Alan Kivitz, Peter E. Lipsky, Richard C. Hubbard, Peter C. Isakson, Kenneth M. Verburg, Shawn Yu, William W. Zhao, Gilbert Geis
JAMA. 1999804 Citations
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd‐Ruediger Burmester, David Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. Genovese, Khalid Ahmed, Jeffrey Alper, N Barkham, Ralph E. Bennett, Francisco J. Blanco, Ricardo Blanco Alonso, Howard Blumstein, Michael S. Brooks, Gerd‐Rüdiger Burmester, Patricia Cagnoli, Paul H. Caldron, Alain Cantagrel, Der‐Yuan Chen, Melvin Churchill, Christine E. Codding, Benard Combe, Peter M.G. Deane, José Del Giudice, Atul Deodhar, Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska
The Lancet. 2017409 CitationsOPEN ACCESS
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
Karel Pavelka, Alan Kivitz, Eva Dokoupilová, Ricardo Blanco, Marco Maradiaga, Hasan Tahir, Luminita Pricop, Mats Andersson, Aimee Readie, Brian Porter
Arthritis Research & Therapy. 2017234 CitationsOPEN ACCESS

How much of the research on Altoona Center for Clinical Research is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
67%
Green
0%
Hybrid
0%
Bronze
0%
Closed
33%
470M+ articles · free account